Single Strain Probiotic + Milk ProteinPlacebo + Milk Protein
Single Strain Probiotic + Milk Protein: • Both conditions matched flavor, color, and serving size
Placebo + Milk Protein: • Both conditions matched flavor, color, and serving size
Study summary
The purpose of this study is to examine the rate and concentration of amino acid absorption after a three-week pattern of milk protein supplementation with and without the addition of a single strain probiotic.
Eligibility
Sex
ALL
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Participants will be male or female between the ages of 18-35 years;
* Participants have not been consuming any nutritional supplements for the preceding 6-week period;
* Participants have not been consuming any ergogenic aids for the preceding 6-week period;
* Participant has provided written and dated informed consent to participate in the study;
* Participant is willing and able to comply with the protocol;
* Participant is apparently healthy and free from disease, as determined by a health history questionnaire;
Exclusion Criteria:
* Participant is allergic to any ingredient in the nutritional supplement or placebo;
* Participant is not pregnant or trying to become pregnant, nor breast feeding;
* Participant reports any unusual adverse events associated with this study that in consultation with the study investigators or their doctor recommends removal from the study;
* Participant currently ingests nicotine or has quit within the last 6 months;
Primary outcome measure(s)
Rate of amino acid absorption — Day 0, Day 22, Day 65 To determine if the addition of a probiotic to milk protein ingestion changes the rate (in minutes) to which amino acids are absorbed into our bloodstream.
Concentration of amino acid absorption — Day 0, Day 22, Day 65 To determine if the addition of a probiotic to milk protein ingestion changes the extent (concentration in millimoles/Liter) to which amino acids are absorbed into our bloodstream.
Trial sites (1)
Facility
City
Region
Status
The University of Mary Hardin-Baylor
Belton
Texas
More The Archer-Daniels-Midland Company trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.